These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30681008)

  • 1. Partial
    Ambike SS; Thakar MR; Patil AA; Gangakhedkar RR; Kurle SN
    AIDS Res Hum Retroviruses; 2019 May; 35(5):505-508. PubMed ID: 30681008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
    Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
    J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance mutations in patients infected with HIV-2 living in Spain.
    Treviño A; de Mendoza C; Caballero E; Rodríguez C; Parra P; Benito R; Cabezas T; Roc L; Aguilera A; Soriano V;
    J Antimicrob Chemother; 2011 Jul; 66(7):1484-8. PubMed ID: 21558334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
    de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
    J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India.
    Nesakumar M; Haribabu H; Cheedarla N; Karunaianantham R; Kailasam N; Sathyamurthi P; Selvachithiram M; Tripathy SP; Hanna LE
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):775-779. PubMed ID: 31001987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.
    Balakrishnan P; Kumarasamy N; Kantor R; Solomon S; Vidya S; Mayer KH; Newstein M; Thyagarajan SP; Katzenstein D; Ramratnam B
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):301-5. PubMed ID: 15943572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.
    Ndembi N; Abraha A; Pilch H; Ichimura H; Mbanya D; Kaptue L; Salata R; Arts EJ
    J Clin Microbiol; 2008 Jan; 46(1):177-84. PubMed ID: 17855574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of HIV-I drug resistance mutations among treatment-naive individuals at a tertiary care centre in south India.
    Kandathil AJ; Kannangai R; Abraham OC; Rupali P; Pulimood SA; Verghese VP; Grant P; Pillay D; Sridharan G
    Int J STD AIDS; 2009 Aug; 20(8):522-6. PubMed ID: 19625581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India.
    Sen S; Tripathy SP; Chimanpure VM; Patil AA; Bagul RD; Paranjape RS
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):489-97. PubMed ID: 17506605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso.
    Ruelle J; Sanou M; Liu HF; Vandenbroucke AT; Duquenne A; Goubau P
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):955-64. PubMed ID: 17725411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic prediction of resistant mutation in HIV-1 pol gene towards the antiretroviral drugs.
    Kumar A; Jadhav C
    Int J Bioinform Res Appl; 2011; 7(1):15-23. PubMed ID: 21441094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.
    Tzou PL; Descamps D; Rhee SY; Raugi DN; Charpentier C; Taveira N; Smith RA; Soriano V; de Mendoza C; Holmes SP; Gottlieb GS; Shafer RW
    J Infect Dis; 2020 Jun; 221(12):1962-1972. PubMed ID: 31965175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Drug Resistance Associated Mutations Among the Anti Retroviral Therapy Exposed HIV-1 Infected Individuals in Manipur, Northeast India.
    Lakhikumar Sharma A; Ramsing Singh T; Ranjana Devi K; Shanjukumar Singh L
    Curr HIV Res; 2016; 14(4):360-70. PubMed ID: 27033350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.
    Bakhouch K; Oulad-Lahcen A; Bensghir R; Blaghen M; Elfilali KM; Ezzikouri S; Abidi O; Hassar M; Wakrim L
    J Infect Dev Ctries; 2009 Jun; 3(5):380-91. PubMed ID: 19759509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HIV type 1 subtype C protease gene: selection of L63P mutation in protease inhibitor-naive Indian patients.
    Neogi U; Sahoo PN; Kumar R; De Costa A; Shet A
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1249-53. PubMed ID: 21453185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.